IP Library Granted Patent US 8,916,360
Granted Patent B2
US 8,916,360 · App. 13/157,575 · Granted Dec 23, 2014

Glycopegylated erythropoietin

Inventors: Shawn DeFrees (North Wales, PA); David A. Zopf (Wayne, PA); Caryn Lang Bowe (Doylestown, PA)
Assignee: Novo Nordisk A/S
C12P21/005A61K38/22A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,916,360
App. No.
13/157,575
Granted
Dec 23, 2014
Kind
B2
Abstract

The present invention provides conjugates between erythropoietin and PEG moieties. The conjugates are linked via an intact glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto a glycosyl residue on the peptide. Also provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.

Claims (14)

1. A cell-free, in vitro method of forming a covalent conjugate between an erythropoietin peptide and poly(ethylene glycol), which method comprises:

(a) providing an erythropoietin peptide,

(b) providing a modified sugar donor comprising an intact glycosyl linking group covalently linked to poly(ethylene glycol), wherein the intact glycosyl linking group has a structure according to the formula:

wherein n is an integer from 0-500, and

(c) covalently attaching the intact glycosyl linking group to a glycosyl or amino acid residue of the erythropoietin peptide by reaction between the erythropoietin peptide and the modified sugar donor, wherein the reaction is catalyzed by a sialyltransferase.

2. The method of claim 1 , wherein the poly(ethylene glycol) has a molecular weight distribution that is essentially homodisperse.

3. The method of claim 1 , wherein the intact glycosyl linking group has a structure according to the formula:

wherein a and b are members independently selected from 0 and 1; and Sia-R has a structure according to the formula:

wherein n is an integer from 0-500.

4. The method of claim 1 , wherein the intact glycosyl linking group is covalently bound to a member selected from the group consisting of (a) an amino acid residue of the peptide which is a member selected from Ser, Thr and Asn; (b) a glycosyl residue covalently bound to an amino acid residue of the peptide which is a member selected from Ser, Thr and Asn; and (c) combinations thereof.

5. The method of claim 3 , wherein a is 0 and b is 0.

6. The method of claim 3 , wherein a is 0 and b is 1.

7. The method of claim 3 , wherein a is 1 and b is 0.

8. The method of claim 3 , wherein a is 1 and b is 1.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2012
From: DEFREES, SHAWN; ZOPF, DAVID A.
To: NOVO NORDISK A/S
Reel/Frame 027528/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2012
From: BOWE, CARYN LANG
To: NOVO NORDISK A/S
Reel/Frame 027528/0179 →
Continuity (12)
Continuation 11982273 · Oct 31, 2007
Division 11144223 · Jun 2, 2005
Continuation In Part 10997405 · Nov 24, 2004
Provisional Application 60685007 · May 25, 2005
Provisional Application 60524989 · Nov 24, 2003
Provisional Application 60539387 · Jan 26, 2004
Provisional Application 60555504 · Mar 22, 2004
Provisional Application 60590573 · Jul 23, 2004
Provisional Application 60592744 · Jul 29, 2004
Provisional Application 60614518 · Sep 29, 2004
Provisional Application 60623387 · Oct 29, 2004
Related Publication 20120107867A1 · May 3, 2012